Stephan Madersbacher

Stephan Madersbacher's AcademicInfluence.com Rankings

Physics

#7449

World Rank

#9482

Historical Rank

physics Degrees

Download Badge

Physics

Stephan Madersbacher's Degrees

Bachelors Physics University of Vienna
Masters Physics University of Vienna
PhD Physics University of Zurich

Why Is Stephan Madersbacher Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephan Madersbacher's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. (2003) (778)
EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. (2015) (743)
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). (2004) (634)
A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. (2015) (553)
Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. (2010) (542)
Urinary incontinence in both sexes: Prevalence rates and impact on quality of life and sexual life (2000) (389)
Effect of high-intensity focused ultrasound on human prostate cancer in vivo. (1995) (373)
Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. (2005) (336)
EAU Guidelines on Benign Prostatic Hyperplasia (BPH) (2001) (331)
High‐grade prostate cancer is associated with low serum testosterone levels (2001) (330)
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. (2008) (299)
Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. (2005) (263)
Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. (2009) (259)
Benign prostatic hyperplasia: age-related tissue-remodeling (2005) (250)
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. (2012) (243)
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. (2013) (231)
The aging lower urinary tract: a comparative urodynamic study of men and women. (1998) (205)
Positive surgical margins after nephron-sparing surgery. (2012) (194)
Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). (2011) (194)
Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? (2005) (174)
Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. (1998) (172)
Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. (2005) (169)
The association between vascular risk factors and lower urinary tract symptoms in both sexes. (2006) (161)
Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. (1994) (159)
Predictors of new-onset decline in kidney function in a general middle-european population. (2007) (158)
Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project. (2000) (151)
Female sexual dysfunction in a healthy austrian cohort: prevalence and risk factors. (2005) (151)
A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporisation and holmium laser enucleation of the prostate. (2009) (136)
A polymorphism in the CYP17 gene is associated with prostate cancer risk (2000) (135)
The long-term outcome of medical therapy for BPH. (2007) (121)
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review (2019) (120)
Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostatectomy predictable? (1997) (117)
Morphology of tissue destruction induced by focused ultrasound. (1993) (117)
Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology. (2000) (115)
Long–Term Outcome of Transrectal High– Intensity Focused Ultrasound Therapy for Benign Prostatic Hyperplasia (2000) (113)
Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. (2007) (113)
Two–Year Results of Transurethral Resection of the Prostate versus Four ‘Less Invasive’ Treatment Options (2000) (109)
Association between lower urinary tract symptoms and erectile dysfunction. (2004) (104)
Tissue ablation in benign prostatic hyperplasia with high-intensity focused ultrasound. (1994) (103)
Polymorphisms of glutathione‐S‐transferase genes (GSTP1, GSTM1 and GSTT1) and prostate‐cancer risk (2001) (99)
Coexpression of gonadotropic hormones and their corresponding FSH‐ and LH/CG‐receptors in the human prostate (1998) (95)
Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? (2008) (92)
The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives. (1997) (91)
Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. (2002) (90)
Is ileal orthotopic bladder substitution with an afferent tubular segment detrimental to the upper urinary tract in the long term? (2002) (88)
Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. (2002) (88)
Age related urodynamic changes in patients with benign prostatic hyperplasia. (1996) (84)
Is the metabolic syndrome an independent risk factor for erectile dysfunction? (2007) (84)
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? (2013) (83)
Risk Factors for Lower Urinary Tract Symptoms in Elderly Men (2000) (83)
The international prostate symptom score in both sexes: A urodynamics‐based comparison (1999) (82)
Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. (2003) (80)
Nocturia is an age‐independent risk factor for hip‐fractures in men (2009) (80)
Prevalence of Lower Urinary Tract Symptoms in Austria as Assessed by an Open Survey of 2,096 Men (1998) (79)
Long-Term Voiding Pattern of Patients With Ileal Orthotopic Bladder Substitutes (2002) (78)
Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk (2003) (76)
Interrelationships of bladder compliance with age, detrusor instability, and obstruction in elderly men with lower urinary tract symptoms (1999) (76)
The impact of varicocelectomy on sperm parameters: a meta-analysis. (2012) (75)
Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T‐cells (2004) (73)
Serum androgen levels in men: impact of health status and age. (2003) (73)
Production of trophoblastic hormones by transitional cell carcinoma of the bladder: association to tumor stage and grade. (1998) (73)
Monoclonal antibodies against the free subunits of human chorionic gonadotrophin. (1990) (73)
Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms? (1997) (69)
The natural history of lower urinary tract symptoms over five years. (2003) (69)
The role of intermittent androgen deprivation in prostate cancer (2007) (68)
Chronic pelvic pain and lower urinary tract symptoms in both sexes: analysis of 2749 participants of an urban health screening project. (2009) (66)
Genetic polymorphisms and prostate cancer risk (2004) (65)
Symptoms suggestive of chronic pelvic pain syndrome in an urban population: prevalence and associations with lower urinary tract symptoms and erectile function. (2007) (65)
Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment (1998) (64)
Systematic Review of the Performance of Noninvasive Tests in Diagnosing Bladder Outlet Obstruction in Men with Lower Urinary Tract Symptoms. (2017) (64)
Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms. (2017) (64)
Vitamin D receptor gene polymorphism and prostate cancer risk (2002) (63)
Risk Factors for Urinary Incontinence in Both Sexes (2001) (61)
Transurethral Resection of the Prostate (2009) (60)
Lower urinary tract symptoms and urinary incontinence in a geriatric cohort – a population‐based analysis (2012) (60)
Frequent use of complementary medicine by prostate cancer patients. (2003) (59)
Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. (1996) (57)
The impact of liver transplantation on endocrine status in men (1996) (57)
Association of polymorphisms within androgen receptor, 5α‐reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men (2002) (55)
Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire (2010) (55)
A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk. (2002) (55)
Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approach. (2011) (53)
High-energy shockwaves and extracorporeal high-intensity focused ultrasound. (2003) (53)
Are lower urinary tract symptoms influenced by metabolic syndrome? (2009) (52)
The natural history of lower urinary tract symptoms in females: analysis of a health screening project. (2007) (51)
Elective open nephron-sparing surgery for renal masses: single-center experience with 129 consecutive patients. (2004) (50)
Free alpha-subunit, free beta-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. (1992) (49)
Palliative transurethral resection of the prostate: functional outcome and impact on survival (2007) (48)
Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis. (2002) (47)
Organ-specific expression pattern of the human growth hormone/placental lactogen gene-cluster in the testis (1997) (44)
Twelve prostate biopsies detect significant cancer volumes (> 0.5 mL) (2000) (43)
A Comparative Cross–Sectional Study of Lower Urinary Tract Symptoms in Both Sexes (2001) (43)
Contemporary cystectomy and urinary diversion (2002) (43)
Incidence and remission of female urinary incontinence over 6.5 years: analysis of a health screening project. (2006) (42)
Lymphatic drainage of prostatic transition and peripheral zones visualized on a three-dimensional workstation. (2001) (42)
The prevalence of lower urinary tract symptoms in Austrian males andassociations with sociodemographic variables (1999) (41)
Sexual Function after Tension-Free Vaginal Tape Procedure (2007) (40)
Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment (2007) (40)
The molecular basis for epitopes on the free beta-subunit of human chorionic gonadotrophin (hCG), its carboxyl-terminal peptide and the hCG beta-core fragment. (1994) (40)
Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk. (2001) (40)
Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis. (2019) (39)
Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases. (2004) (39)
Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation (2015) (38)
The influence of family history on prostate cancer risk: implications for clinical management (2011) (38)
Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia: therapeutic options for the man at risk (2007) (38)
Selective growth hormone/placental lactogen gene transcription and hormone production in pre- and postmenopausal human ovaries. (1997) (38)
Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application. (1997) (37)
Human chorionic gonadotropin (hCG) and its free subunits in hydrocele fluids and neoplastic tissue of testicular cancer patients: insights into the in vivo hCG-secretion pattern. (1994) (37)
Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: real life experience in Austria (2006) (36)
Serum glycoprotein hormones and their free α-subunit in a healthy elderly population selected according to the SENIEUR protocol. Analyses with ultrasensitive time resolved fluoroimmunoassays (1993) (36)
Antibodies and immunoassays. (2000) (36)
Impact of different sized catheters on pressure‐flow studies in patients with benign prostatic hyperplasia (1996) (36)
Free alpha subunit of human chorionic gonadotrophin: molecular basis of immunologically and biologically active domains. (1994) (35)
Landmarks in hormonal therapy for prostate cancer (2012) (35)
Vascular risk factors and erectile dysfunction in a cohort of healthy men (2006) (35)
Reoperation Rates and Mortality After Transurethral and Open Prostatectomy in a Long-term Nationwide Analysis: Have We Improved Over a Decade? (2018) (35)
Perioperative Complications and 90-Day Mortality of Radical Cystectomy in the Elderly (75+): A Retrospective, Multicentre Study (2014) (33)
Time-resolved immunofluorometry and other frequently used immunoassay types for follicle-stimulating hormone compared by using identical monoclonal antibodies. (1993) (33)
Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55:121-30. (2009) (33)
Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men. (2002) (33)
Is there an association between lower urinary tract symptoms and cardiovascular risk in men? A cross sectional and longitudinal analysis. (2011) (33)
Relationship between testosterone serum levels and lifestyle in aging men (2005) (33)
Reduced circulating androgen bioactivity in patients with prostate cancer (2003) (32)
Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality (2001) (32)
Re: Thomas Hambrock, Caroline Hoeks, Christina Hulsbergen-van de Kaa, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 2012;61:17 (2012) (32)
Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement. (2001) (31)
Minimally invasive treatment for benign prostatic hyperplasia. (1998) (31)
Endocrine patterns in patients with benign and malignant prostatic diseases (2000) (31)
The Impact of Urinary Extravasation after Radical Retropubic Prostatectomy on Urinary Incontinence and Anastomotic Strictures (1999) (30)
Double wavelength measurement of 3,3',5,5'-tetramethylbenzidine (TMB) provides a three-fold enhancement of the ELISA measuring range. (1991) (29)
Outcome analysis of minimally invasive treatments for benign prostatic hyperplasia. (1999) (29)
Plant extracts: sense or nonsense? (2008) (29)
Low-energy extracorporeal shock wave therapy for chronic pelvic pain syndrome: finally, the magic bullet? (2009) (28)
Nocturnal polyuria: it's all about definition, and be Patient! (2013) (28)
Human chorionic gonadotropin (hCG) in the male reproductive tract (2007) (27)
Radical prostatectomy in Austria: a nationwide analysis of 16,524 cases. (2007) (26)
Impact of the Use of Bowel for Urinary Diversion on Perioperative Complications and 90-Day Mortality in Patients Aged 75 Years or Older (2015) (25)
Comparison of Complications from Radical Cystectomy between Old-Old versus Oldest-Old Patients (2014) (25)
The natural history of the overactive bladder syndrome in females: A long‐term analysis of a health screening project (2011) (25)
Adjustable Continence Therapy for Female Urinary Incontinence: A Minimally Invasive Option for Difficult Cases (2008) (25)
The association between lower urinary tract symptoms and renal function in men: a cross-sectional and 5-year longitudinal analysis. (2006) (24)
Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls. (2005) (23)
Update of the ICUD–SIU International Consultation on Bladder Cancer 2018: urinary diversion (2018) (23)
The urodynamic impact of transrectal high-intensity focused ultrasound on bladder outflow obstruction. (1996) (22)
Is penile atherosclerosis the link between erectile dysfunction and cardiovascular risk? An autopsy study (2012) (21)
Comparative Analysis of Gender-Related Differences in Symptoms and Referral Patterns prior to Initial Diagnosis of Urothelial Carcinoma of the Bladder: A Prospective Cohort Study (2014) (21)
Serial tissue polypeptide specific antigen determination in the followup of hormone treated carcinoma of the prostate. (1997) (20)
Association of DHEA-S and estradiol serum levels to symptoms of aging men (2002) (20)
A Relevant Midterm (12 Months) Placebo Effect on Lower Urinary Tract Symptoms and Maximum Flow Rate in Male Lower Urinary Tract Symptom and Benign Prostatic Hyperplasia-A Meta-analysis. (2017) (20)
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia (2020) (20)
A low‐molecular‐weight fraction of human seminal plasma activates adenylyl cyclase and induces caspase 3‐independent apoptosis in prostatic epithelial cells by decreasing mitochondrial potential and Bcl‐2/Bax ratio (2001) (20)
Pathogenesis and management of recurrent urinary tract infection in women (2000) (19)
The testis-specific expression pattern of the growth hormone/placental lactogen (GH/PL) gene cluster changes with malignancy. (1999) (19)
Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival (2019) (19)
Impact of Overactive Bladder Symptoms on Sexuality in Both Sexes (2010) (19)
Serum androgen levels and their association to depression and Alzheimer dementia in a cohort of 75-year-old men over 5 years: results of the VITA study (2009) (19)
Increased ELISA sensitivity using a modified method for conjugating horseradish peroxidase to monoclonal antibodies. (1992) (19)
Cognitive and mood side effects of lower urinary tract medication (2019) (18)
Eutopic production of human chorionic gonadotropin beta (hCG beta) and luteinizing hormone beta (hLH beta) in the human testis. (1994) (18)
Urinary Tract Symptoms including Benign Prostatic Obstruction (2015) (18)
Phytotherapy Adds to the Therapeutic Armamentarium for the Treatment of Mild-To-Moderate Lower Urinary Tract Symptoms in Men (2019) (18)
Integrative analysis of prostate cancer aggressiveness (2013) (18)
Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. (2021) (18)
European Association of Urology GUIDELINES ON BENIGN PROSTATIC HYPERPLASIA (2001) (18)
Emergency nephrectomy due to severe urosepsis: a retrospective, multicentre analysis of 65 cases (2009) (16)
The Microbiome in Benign Renal Tissue and in Renal Cell Carcinoma (2019) (16)
Bladder preservation in octogenarians with invasive bladder cancer. (2010) (16)
Vascular risk factors and their association to serum androgen levels in a population-based cohort of 75-year-old men over 5 years: results of the VITA study (2010) (16)
Medical Management of BPH: Role of Plant Extracts (2007) (16)
Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer. (2013) (15)
Re: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Eur Urol 2005;47:137-46. (2005) (15)
Sex Differences of ≥pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients (2015) (14)
The Impact of Gender on Tumour Stage in In-House Complications and Choice of Urinary Diversion: Results of the Austrian Cystectomy Registry (2017) (13)
Stents for prostatic diseases: any progress after 25 years? (2006) (13)
Thermal ablation of BPH with transrectal high-intensity focused ultrasound. (1994) (13)
Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015 (2015) (13)
Does tumor-derived human chorionic gonadotropin act as a thyroid stimulator in vivo? (1993) (13)
[The testis as eutopic production site of human growth hormone, placental lactogen and prolactin: possible autocrine/paracrine effects on testicular function]. (1996) (13)
Radical prostatectomy in Austria from 1992 to 2009: an updated nationwide analysis of 33,580 cases. (2012) (12)
Prevalence and risk factors for erectile dysfunction in Austria — Analysis of a health screening project (2003) (12)
10 years follow‐up after mid‐urethral sling implantation: high rate of cure yet a re‐occurrence of OAB‐symptoms (2017) (12)
MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibility. (2013) (12)
The Long-Term Effect of Radical Prostatectomy on Erectile Function, Urinary Continence, and Lower Urinary Tract Symptoms: A Comparison to Age-Matched Healthy Controls (2017) (12)
Radical Cystectomy for Bladder Cancer in the 70+ Population: A Nation-Wide Registry Analysis of 845 Patients (2010) (12)
Common genetic polymorphisms of AURKA and prostate cancer risk (2009) (12)
Impact of gender on tumor stage and survival of upper urinary tract urothelial cancer (2016) (12)
[Phytotherapy for BPS. Which products can still be prescribed?]. (2005) (11)
Urodynamics prior to prostatectomy: pro. (2004) (11)
[Minimally invasive therapy of benign prostatic hyperplasia with focussed ultrasound]. (1995) (11)
Sacral distribution of prostatic lymph nodes visualized on spiral computed tomography with three‐dimensional reconstruction (2002) (11)
The relationship between cerebral white matter hyperintensities and lower urinary tract function in a population based, geriatric cohort (2014) (10)
Re: Tamsulosin and the Risk of Dementia in Older Men with Benign Prostatic Hyperplasia. (2018) (10)
The development of benign prostatic hyperplasia by trans-differentiation of prostatic stromal cells (2002) (10)
Rezūm water vapor therapy in multimorbid patients with urinary retention and catheter dependency (2021) (10)
Prevalence of Lower Urinary Tract Symptoms in Austrian Males: Update 2009 (2011) (10)
Can a Simple Geriatric Assessment Predict the Outcome of TURP? (2020) (10)
Abiraterone acetate, enzalutamide and their sequence for castration-resistant prostate cancer (2018) (9)
Tumor markers in hydrocele fluids of patients with benign and malignant scrotal diseases. (1997) (9)
Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample (2009) (9)
High‐intensity focused ultrasound for prostatic tissue ablation (1996) (9)
Minimally Invasive Treatment of BPH: An Update (2004) (9)
C109 Laparoscopic and open partial nephrectomy: a matched pair comparison of 200 patients (2009) (9)
The effect on erectile function of 103palladium implantation for localized prostate cancer (2005) (9)
Reassessment of the role of human placental lactogen in physiological non-pregnant and pathological conditions. (2009) (9)
Proposal for a standardized PSA doubling-time calculation. (2010) (8)
After three randomised controlled trials comparing 120-W high-performance-system potassium-titanyl-phosphate laser vaporisation to transurethral resection of the prostate (TURP), is this procedure finally first-line, outdated, or still not surpassing TURP? (2012) (8)
Abiraterone for castration-resistant prostate cancer: adherence, survival and hospitalization (2016) (8)
Prostate cancer in senior adults: over- or undertreated? (2009) (7)
EUROPEAN ASSOCIATION OF UROLOGY (2004) (7)
Urological applications of high‐intensity focused ultrasound (1995) (7)
Holmium laser‐enucleation of the prostate enables early catheter removal (2004) (7)
Management of Lower Urinary Tract Symptoms of Eldery Men in Austria (2001) (7)
Gonadotrophin secretion patterns in testicular cancer patients with greatly increased human chorionic gonadotrophin serum concentrations. (1999) (6)
A Comparative Study of a Double-Line versus a Fan-Shaped Techniquefor Obtaining TransrectalUltrasound-Guided Biopsies of the Prostate (1998) (6)
High -Intensity Focused Ultrasound in Urology (1996) (6)
Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? (2004) (6)
Men's bladder health: urinary incontinence in the elderly (Part I) (2005) (6)
Safety, Efficacy and Impact on Patients’ Quality of Life of a Long–Term Treatment with the α1–Blocker Alfuzosin in Symptomatic Patients with BPH (2000) (6)
Prevalence of lower urinary tract symptoms and urinary incontinence in the elderly: recent data from Austria. (2000) (6)
804 IMMEDIATE OR DEFERRED ANDROGEN DEPRIVATION FOR PATIENTS WITH PROSTATE CANCER AND NO LOCAL TREATMENT OF THE PROSTATE: LONG TERM RESULTS OF EORTC 30891 (2011) (5)
Bladder cancer in nonagenarians: a multicentre study of 123 patients (2018) (5)
Caveats when interpreting intravenous urograms following ileal orthotopic bladder substitution (2004) (5)
Editorial comment on: GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. (2008) (5)
Re: Comparison of Prostatic Artery Embolization (PAE) Versus Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia: Randomised, Open Label, Non-inferiority Trial. (2018) (4)
Ideal timing of indwelling catheter removal after robot-assisted radical prostatectomy with a running barbed suture technique: a prospective analysis of 425 consecutive patients (2019) (4)
Collaborative Review - Benign Prostatic Enlargement Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement (2010) (4)
Alternatives to TURP: Outcome Analysis and Indication Tuning (2002) (4)
Diagnostic value of free subunits of serum chorionic gonadotropin in testicular cancer (1990) (4)
Prostate cancer at the peripheral end of a prostate biopsy specimen as assessed by a novel marking technique may indicate increased risk of locally advanced disease (2011) (4)
[Combination therapy of benign prostate syndrome/lower urinary tract symptoms]. (2013) (3)
773 Abiraterone for castration resistant prostate cancer: Adherence, survival and hospitalization: Analysis of a medical claims database (2016) (3)
Greenlight Photovaporisation of the Prostate: Now Ready for Prime Time. (2016) (3)
Gonadotrophin secretion patterns in testicular cancer patients with greatly increased human chorionic gonadotrophin serum concentrations (1998) (3)
Re: WATER: A Double-blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. (2018) (3)
Is left ventricular systolic dysfunction a risk factor for erectile dysfunction? (2010) (3)
Radical prostatectomies in Austria, 1997–2004 (2008) (3)
Periarterial papaverine improves early postoperative renal function after retroperitoneoscopic partial nephrectomy (2013) (3)
354 LONG TERM RESULTS OF IMMEDIATE VERSUS DEFERRED ANDROGEN DEPRI-VATION IN PATIENTS WITH NO LOCAL TREATMENT FOR T0–4 N0–2 M0 PROSTATE CANCER (EORTC 30891) (2011) (3)
Re: Chemo-ablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction. (2002) (3)
Is there a place for indwelling transurethral catheterization in women with febrile urinary tract infection? A prospective randomized trial (2016) (3)
Re: Availability of Evidence of Benefits on Overall Survival and Quality of Life of Cancer Drugs Approved by European Medicines Agency: Retrospective Cohort Study of Drug Approvals 2009-2013. (2017) (3)
Does tumour-derived hCG stimulate thyroid? (1991) (3)
Words of Wisdom. Re: the learning curve for surgical margins after open radical prostatectomy: implications for the use of margin status as an oncologic endpoint. (2011) (3)
Men's bladder health: urinary incontinence in the elderly (Part II): Management (2005) (2)
[Minimal invasive therapy of benign prostatic hyperplasia]. (1996) (2)
[Epidemiology of BPH and medication approaches]. (2006) (2)
[Current treatment of locally advanced and metastatic prostate cancer]. (2011) (2)
[Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma]. (2001) (2)
Impact of rural/urban residence on relative survival (RS) in patients with kidney cancer: An analysis of 14576 patients from the Austrian National Cancer Registry (ANCR). (2017) (2)
HAS BLOOD VOLUME AN IMPACT ON SERUM PSA LEVELS (2008) (2)
Prostatakarzinom-Screening: Sinn oder Unsinn? (2009) (2)
Prognostic factors in patients with pelvic lymph node metastases of bladder cancer (2003) (2)
OnabotulinumtoxinA for idiopathic overactive bladder symptoms: many answers but more questions. (2013) (2)
The future of urology: nonagenarians admitted to a urological ward (2021) (2)
Systematic review of the diagnostic performance of non-invasive tests in diagnosing bladder outlet obstruction or detrusor underactivity in men with lower urinary tract symptoms (2015) (2)
Genetic polymorphisms of cytochrome P4501A1 and glutathione S-transferase M1: a lung cancer case control study (1999) (2)
241 Growth hormone, insulin-like growth factor-1 and growth hormone response to growth hormone releasing hormone in the elderly male are augmented considerably by donepezil, a drug for Alzheimer's disease (2004) (2)
RADICAL PROSTATECTOMY IN PATIENTS WITH GLEASON SCORE 8-10 – A RETROSPECTIVE ANALYSIS OF 199 PATIENTS IN 2 REFERRAL HOSPITALS (2008) (2)
[Synchronous bilateral renal cell cancer with a single ovarian metastasis and a fibromuscular dysplasia of the renal artery]. (2007) (2)
Postmicturition Dribble: A Physiological Phenomenon? (2019) (2)
[Tissue ablation by high-intensity focused ultrasound in benign prostatic hypertrophy]. (1993) (2)
Re: Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. (2011) (2)
Long term outcome of ileal conduit urinary diversion (2002) (2)
SEARCH FOR AUTOREACTIVE ANTIBODIES IN THE SERA OF PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (1999) (1)
Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study (2014) (1)
Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU) (2017) (1)
Secretion Pattern of FSH in Patients Suffering from Chorionic Gonadotropin-Producing Tumors (1992) (1)
729 THE NATURAL HISTORY OF LOWER URINARY TRACT SYMPTOMS IN FEMALES OVER 6.5 YEARS: ANALYSIS OF A HEALTH SCREENING PROJECT (2007) (1)
RADICAL PROSTATECTOMY IN AUSTRIA: A NATION-WIDE ANALYSIS OF 16,524 CASES (2006) (1)
Chapter 56 – What is the Newest Technology in Treating Prostate Cancer? Transrectal High-intensity Focused Ultrasound (2003) (1)
[Modulation of hCG synthesis by alpha tumor necrosis factor in JAR choriocarcinoma cells]. (1990) (1)
[Antigenic determinants of human chorionic gonadotropin (hCG): identification of epitopes and determination of their biological functions, for use in immunometric test systems and development of a fertility regulating vaccine]. (1993) (1)
Systematic review of the performance of non-invasive tests in diagnosing bladder outlet obstruction in men with lower urinary tract symptoms (2018) (1)
Grade IV Renal Trauma in a Patient with a Solitary Kidney (2008) (1)
[How to use PSA in 2009]. (2009) (1)
Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study (2022) (1)
THE INNOCENT PROSTATE: A COMPARISON OF CHRONIC PELVIC PAIN AND LOWER URINARY TRACT SYMPTOMS IN BOTH SEXES (2008) (1)
801 TIME TO PROGRESSION SHOULD NOT BE USED TO INFER THE ULTIMATE BENEFIT OF IMMEDIATE VERSUS DEFERRED/SALVAGE ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER (2011) (1)
Management of nonmetastatic muscle invasive bladder cancer in the elderly (2019) (1)
587 The response to sublethal heat treatment of prostatic tumour cells and of prostatic tumour infiltrating T-cells (2004) (1)
The long‐term outcome of urethrotomy for primary urethral strictures: a population‐based analysis (2021) (1)
VASCULAR RISK FACTORS AND ERECTILE DYSFUNCTION IN HEALTHY MEN (2006) (1)
Ureterosigmoidostomy, Conduit and Continent Urinary Diversion (1999) (1)
Null Results in Brief A Polymorphism in the UDP-Glucuronosyltransferase 2 B 15 Gene ( D 85 Y ) Is Not Associated with Prostate Cancer Risk (2002) (1)
Relation of Body Mass Index (BMI) with the risk of developing BPH (2002) (1)
Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria (2021) (1)
Re: Effect of Dutasteride on the Risk of Prostate Cancer (2010) (1)
The surgical point of view of the geriatric patient — Urinary incontinence (2001) (1)
Association of PSA, testosterone, folistatin, activin and cortisol serum levels in patients with benign prostate hyperplasia and prostate cancer (2003) (1)
Re: Efficacy and Safety of Tadalafil 5mg Once Daily in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia in Men Aged ≥75 years: Integrated Analyses of Pooled Data from Multinational, Randomized, Placebo-controlled Clinical Studies. (2017) (1)
The relationship of local to distant failure in pelvic lymph node positive patients after radical cystectomy (2002) (1)
Re: Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study. (2007) (1)
TPS In Prostate Cancer (2008) (1)
UvA-DARE ( Digital Academic Repository ) Association of polymorphisms in CYP 19 A 1 and CYP 3 A 4 genes with lower urinary tract symptoms , prostate volume , uroflow and PSA in a population-based sample (2017) (1)
244 Impact of BMI, physical and social activity, nicotine- and alcohol-consumption, stress and sleep characteristics on serum levels of testosterone and free testosterone (2004) (1)
Surgery in renal cell carcinoma—when, whom and how? (2019) (1)
Has blood volume an impact on serum PSA levels? (2010) (1)
Hormonal Changes in Ageing Men (2004) (1)
[Benign prostate hyperplasia: success and limitations of pharmacological therapy]. (2007) (1)
UP-01.042 A Retrospective Evaluation of Radical Cystectomy Versus Bladder Preservation Therapy in Patients 80 Years Old and Older with Muscle-Invasive Bladder Cancer (2011) (0)
Nephron sparing surgery: Single center experience in 123 patients (2003) (0)
EMERGENCY NEPHRECTOMY DUE TO SEVERE UROSEPSIS: A RETROSPECTIVE MULTICENTRE ANALYSIS OVER 12 YEARS (2008) (0)
Re: Functional Outcomes After Transurethral Resection of the Prostate in Nursing Home Residents. (2017) (0)
65 10 years follow-up after tension-free vaginal tapes for the treatment of female stress urinary incontinence: High rate of cure yet a re-occurrence of OAB-symptoms (2015) (0)
989Palliative transurethral resection of the prostate TURP — A consecutive series of 89 patients (2005) (0)
188 PREVALENCE OF THE CHRONIC PELVIC PAIN SYNDROME IN AN URBAN POPULATION: ASSOCIATIONS WITH LOWER URINARY TRACT SYMPTOMS AND ERECTILE FUNCTION (2007) (0)
Contents Vol. 87, 2011 (2011) (0)
Nephron sparing surgery for complex renal cysts classified as Bosniak III and IV (2003) (0)
Re: Water Vapor Thermal Therapy to Alleviate Catheter-dependent Urinary Retention Secondary to Benign Prostatic Hyperplasia. (2021) (0)
IS THERE AN ASSOCIATION BETWEEN LATE ONSET HYPOGONADISM (LOH) AND VASCULAR RISK FACTORS? RESULTS FROM THE VITA-STUDY (2008) (0)
115 Gender differences for bladder cancer survival in Austria: A descriptive, long-term, nation-wide analysis involving 27.395 patients (2014) (0)
Association of polymorphisms in CYP 19 A 1 and CYP 3 A 4 genes with lower urinary tract symptoms , prostate volume , uroflow and PSA in a population-based sample (2009) (0)
Editorial. Some contemporary aspects within the field of Urology. (2009) (0)
OC-0073: Preservation of erectile function after prostate permanent implantation for localized prostate cancer (2014) (0)
51 ASSOCIATION OF A POLYMORPHISM IN THE CYP3A4-GENE WITH BENIGN PROSTATIC HYPERPLASIA IN A POPULATION BASED SAMPLE (2007) (0)
Abstracts of the 11th Annual Meeting of the German Society of Andrology (1999) (0)
Re: Objective Measures of Renal Mass Anatomic Com- plexity Predict Rates of Major Complications Following Partial Nephrectomy (2013) (0)
Comment on: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Author's reply (2005) (0)
757 HOW OFTEN IS RADICAL PROSTATECTOMY OR BRACHYTHERAPY NOT INDICATED BASED ON A 10 YRS SURVIVAL ESTIMATE (2009) (0)
789 Radical prostatectomy in Austria from 1992-2009, a nation-wide analysis of 33.580 cases (2012) (0)
High-Grade ProstateCancer IsAssociatedWith LowSerumTestosterone Levels (0)
Subject Index Vol. 37, 2000 (2000) (0)
Monoclonal antibodies as tools for the detection and removal of cross-contaminants in international hormone reference preparations (1989) (0)
782 RADICAL CYSTECTOMY IN THE ELDERLY IN AUSTRIA-A NATIONWIDE SERIES OF 845 PATIENTS (2007) (0)
205 IS HEART FAILURE AN INDEPENDENT RISK FACTOR FOR ED (2009) (0)
Active surveillance in Austria: An online registry of the Qualitätspartnerschaft Urologie (QuapU) (2016) (0)
Chapter 21 Risk-adapted management of BPH (2011) (0)
756 LOW DOSE BRACHYTHERAPY WITH PERMANENT IMPLANTS FOR LOCALIZED PROSTATE CANCER: THE VIENNA EXPERIENCE (2009) (0)
Phyto-oestrogens in BPH and prostate cancer patients (2003) (0)
The impact of gender on tumour stage, in house complications and choice of urinary diversion – results of the Austrian Cystectomy Registry (2016) (0)
Editorial comment. (2010) (0)
Methicillin-resistant Staphylococcus aureus (MRSA) in an Austrian urological department: 10 years experience covering 95.161 patients (2013) (0)
Responsiveness to medical benign prostatic hyperplasia therapy: is there a genetic factor? (2016) (0)
Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole GL, Bostwick DG, Brawley OW, et al. REDUCE Study Group. N Engl J Med 2010;362:1192-202. (2010) (0)
Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors. (2005) (0)
The impact of gender on tumour stage and survival following upper urinary tract urothelial cancer – a population based study (2016) (0)
69 Phyto-oestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association to prostatic diseases (2004) (0)
Deterioration of the upper urinary tract following ileal bladder substitution: if, when and why? (2003) (0)
THE CHIMPANZEE AS A MODEL OF HUMAN BENIGN PROSTATIC HYPERPLASIA (1999) (0)
Treatment of benign prostatic hyperplasia with high intensity focused ultrasound: A review (1995) (0)
This month in investigative urology. The chimpanzee as a model of human benign prostatic hyperplasia. (1999) (0)
787 LONG-TERM ERECTILE FUNCTION AFTER RADICAL RETROPUBIC PROSTATECTOMY: A COMPARISON TO AGE-MATCHED HEALTHY CONTROLS (2010) (0)
Long term relative survival (RS) in patients with primary metastatic kidney cancer (primary mRCC): An analysis of 2,167 patients from the Austrian National Cancer Registry (ANCR) (2019) (0)
575 Adherence to oral anticholinergics: A long-term, population-based analysis within an equal access health care system of 24.319 patients (2014) (0)
587Reoperation, mortality and myocardial infarction after transurethral and open prostatectomy: A nation-wide, long-term analysis of 23.123 cases (2005) (0)
Words of wisdom: Re: Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer. (2013) (0)
[Prostatic carcinoma screening: sense ur nonsense?]. (2009) (0)
581 Lower urinary tract symptoms and urinary incontinence in a population-based 85-years old cohort (2012) (0)
Radical C ystectomy f or B ladder C ancer T oday—A Homogeneous S eries W ithout N eoadjuvant T herapy (2003) (0)
Long term relative survival (RS) in patients with primary metastatic kidney cancer: An analysis of 2,167 patients from the Austrian National Cancer Registry (ANCR). (2019) (0)
[Contemporary medical management of the benign prostatic syndrome]. (2008) (0)
446 Impact of permanent implantation of palladium 103 for localized prostate cancer on erectile function: A prospective study (2004) (0)
Faculty Opinions recommendation of Saw palmetto for benign prostatic hyperplasia. (2006) (0)
211 5-YEARS LONGITUDINAL CHANGES OF TESTOSTERONE AND DHEAS IN 75YRS OLD MEN: RESULTS OF THE VITA-STUDY (2009) (0)
Contents Vol. 94, 2015 (2015) (0)
[Immunometric tests system for glycoprotein hormones and their free subunits]. (1990) (0)
748 Effect of baseline variables on acute urinary retention and surgery related to benign prostatic hyperplasia in men from the combination of avodart and tamsulosin (CombAT) study (2012) (0)
Measurement of human chorionic gonadotropin and its free subunits under physiological and pathological conditions (1988) (0)
541 ENDOSCOPIC PARTIAL NEPHRECTOMY: MATCHED PAIR COMPARATIVE ANALYSIS OF TRANSPERITONEAL AND RETROPERITONEAL APPROACH (2010) (0)
Words of wisdom: re: intermittent androgen suppression for rising PSA level after radiotherapy. (2013) (0)
Reoperation rates and mortality after transurethral and open prostatectomy in a long-term nation-wide analysis: Have we improved over a decade? (2018) (0)
992 Identification of prevalence and combined risk-factors for LUTS and ED in a population of 50plus: Results of a health-screening project with validated questionnaires (2013) (0)
Long term overall survival (OS) in patients with primary metastatic kidney cancer: An analysis of 1468 patients from the Austrian National Cancer Registry (ANCR). (2017) (0)
[Medical treatment of male lower urinary tract symptoms: what's new?] (2022) (0)
Epidemiology and risk factors of nephrolithiasis in a health screening study in Vienna (2002) (0)
352 TIME TO DISEASE PROGRESSION IS NOT AN APPROPRIATE ENDPOINT IN STUDIES OF IMMEDIATE VERSUS DEFERRED/SALVAGE ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER (2011) (0)
Re: Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. (2009) (0)
Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9. (2010) (0)
Reply (2013) (0)
Long term overall survival (OS) in patients with primary metastatic kidney cancer: an analysis of 1468 patients from the Austrian National Cancer Registry (ANCR) (2017) (0)
Contents Vol. 37, 2000 (2000) (0)
367Prevalence of prostatitis symptoms and lower urinary tract symptoms (LUTS) in 1759 men using validated questionnaires (2005) (0)
Re: Pharmacological Prevention of Side Effects of Androgen Deprivation Therapy, A New Challenge? (2011) (0)
Conservative Treatment of Benign Prostatic Hyperplasia Part 2 in a Series on Benign Prostatic Hyperplasia (2007) (0)
Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre (2023) (0)
Follow-Up of Bladder Cancer (2019) (0)
[Antigenic determinants of human chorionic gonadotropin (hCG): identification of epitopes and their significance for biological functions for the establishment of immunometric assays and for the development of a fertility regulating vaccine] (1993) (0)
Knowledge on the male reproductive tract and testicular cancer among adolescents in Austria. (2023) (0)
PO-223 12 YEARS OF EXPERIENCE IN PERMANENT IMPLANTATION OF THE PROSTATE WITH PD-103 AND I- 125 SEEDS (2012) (0)
Local TNF-α and Systemic IFN-α-2b for the Treatment of Locally Advanced Hormone-Resistant Prostatic Carcinoma (2008) (0)
Testicular tumor markers in the spermatic vein - correlation to pathology, stage and outcome. (2021) (0)
ELECTIVE NEPHRON-SPARING SURGERY FOR RENAL MASSES: COMPARISON OF OPEN AND LAPAROSCOPIC APPROACH IN A BICENTRE ANALYSIS (2008) (0)
MORBIDITY AFTER LONG-TERM ANDROGEN DEPRIVATION – A MATCHED PAIR COMPARISON TO RADICAL PROSTATECTOMY AND EXTERNAL BEAM IRRADIATION (2006) (0)
292 LONG TERM OVERALL SURVIVAL IN RENAL CELL CARCINOMA PATIENTS: ANALYSIS OF THE AUSTRIAN CANCER REGISTRY (2010) (0)
Reply: Landmarks in hormonal therapy for prostate cancer. (2013) (0)
305 CAN ANDROGEN STATUS, DURATION OF ED OR PARTNERSHIP-STATUS PREDICT PDE5-INHIBITOR SUCCESS IN THE FIRST-LINE TREATMENT OF MEN WITH ED? (2010) (0)
Words of Wisdom. Re: identification of late-onset hypogonadism in middle-aged and elderly men. (2011) (0)
Subject Index Vol. 85, 2010 (2010) (0)
[Current drug therapy of benign prostatic hyperplasia]. (1996) (0)
443 Quality of life and lower urinary tract symptoms of men with prostate cancer treated by radical prostatectomy or percutaneous radiotherapy (2004) (0)
OAB without obstruction (2009) (0)
812 BRACHYTHERAPY WITH PD103 AND J125 FOR LOCALIZED PROSTATE CANCER: A COMPARATIVE ANALYSIS OF EFFICACY AND MORBIDITY BETWEEN TWO ISOTOPES (2007) (0)
207 15 ERECTILE DYSFUNCTION AN AGE-INDEPENDENT PREDICTOR FOR CARDIOVASCULAR EVENTS? (2009) (0)
Genetic risk factors for low serum testosterone levels in prostate cancer (2003) (0)
1144 Real life practice patterns of oral TKI and mTOR-inhibitors in patients with metastasised renal cell carcinoma. An analysis of the Vienna public health insurance database (2014) (0)
Trends in the Diagnosis and Management of Benign Hyperplasia Prostate in Indonesia (2011) (0)
17 What is a normal sexual life in women (2004) (0)
Time-ResolvedImmunofluorometry and OtherFrequentlyUsed Immunoassay Types for Follicle-Stimulating HormoneComparedby UsingIdenticalMonoclonal Antibodies (1993) (0)
ARE BODY MASS INDEX OR WAIST/HIP-RATIO INDEPENDENT RISK FACTORS FOR ERECTILE DYSFUNCTION OR LOWER URINARY TRACT SYMPTOMS? (2006) (0)
Re: De Castro et al.: Effect of flexible cystoscopy on serum prostate-specific antigen values. (Urology 2009;73:237-240). (2009) (0)
583 THE PREVALENCE OF SYMPTOMS RELATED TO INTERSTITIAL CYSTITIS IN APPARENTLY HEALTHY WOMEN (2007) (0)
533 PERIARTERIAL PAPAVERINE IMPROVES POSTOPERATIVE RENAL FUNCTION AFTER RETROPERITONEOSCOPIC PARTIAL NEPHRECTOMY (2010) (0)
Testicular expression of human protein hormones (1996) (0)
Editorial comment. (2011) (0)
Editorial comment on: holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. (2008) (0)
Is ileal orthotopic bladder substitution with an isoperistaltic tubular segment detrimental to the upper urinary tract in the long term (2002) (0)
Re: Medication Discontinuation Following Transurethral Prostatectomy: An Unrecognized Effectiveness Measure? (2021) (0)
501 ARE LOWER URINARY TRACT SYMPTOMS A RISK FACTOR FOR FUTURE CARDIOVASCULAR EVENTS (2010) (0)
Significance of the free α- and free β-subunits of human chorionic gonadotropin in choriocarcinoma (1989) (0)
1343: Minimal Invasive Treatment of Female Urinary Incontinence with Adjustable Continence Therapy (2007) (0)
Contents Vol. 85, 2010 (2010) (0)
Bladder cancer in nonagenarians: A retrospective, multicenter study of 123 patients (2018) (0)
649: Radical Prostatectomy in Austria: A Nation-Wide Analysis of 16.524 Cases (2006) (0)
THE NATURAL HISTORY OF FEMALE URINARY INCONTINENCE OVER 5 YEARS (2006) (0)
High-intensity focused ultrasound (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephan Madersbacher?

Stephan Madersbacher is affiliated with the following schools:

ETH Zurich
Stanford University
University of Bern
University of Vienna
University of Zurich